Astrana Health Enters Material Definitive Agreement

Ticker: ASTH · Form: 8-K · Filed: May 21, 2024 · CIK: 1083446

Astrana Health, INC. 8-K Filing Summary
FieldDetail
CompanyAstrana Health, INC. (ASTH)
Form Type8-K
Filed DateMay 21, 2024
Risk Levelmedium
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, financial-obligation

TL;DR

Astrana Health just signed a big deal, new financial obligation incoming.

AI Summary

On May 20, 2024, Astrana Health, Inc. entered into a Material Definitive Agreement related to a direct financial obligation. The company, formerly known as Apollo Medical Holdings, Inc., filed an 8-K report detailing this obligation.

Why It Matters

This filing indicates a new financial commitment or obligation for Astrana Health, which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Entering into new financial obligations can introduce financial risk if not managed effectively.

Key Players & Entities

FAQ

What is the nature of the Material Definitive Agreement entered into by Astrana Health?

The filing indicates the agreement is related to a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on May 20, 2024.

What was Astrana Health's former company name?

Astrana Health, Inc. was formerly known as Apollo Medical Holdings, Inc.

In which state was Astrana Health incorporated?

Astrana Health, Inc. was incorporated in Delaware.

What is the business address of Astrana Health?

The business address is 1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA 91801.

Filing Stats: 638 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-05-21 06:02:35

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On May 20, 2024, Astrana Health, Inc. (the "Company") entered into a Fourth Amendment to Amended and Restated Credit Agreement (the "Credit Agreement Amendment") with the banks and other financial institutions party thereto and Truist Bank, as administrative agent, which amends the Amended and Restated Credit Agreement, dated as of June 16, 2021, entered into among the Company, the lenders party thereto and Truist Bank, as administrative agent (as amended, the "Credit Agreement"). The Credit Agreement Amendment updates the letter of credit provisions in the Credit Agreement to provide the Company with the ability to have letters of credit issued under the Credit Agreement that extend beyond the maturity date of the Credit Agreement. The above description of the Credit Agreement Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Credit Agreement Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

03 Creation of a Direct

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this item.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Fourth Amendment to Amended and Restated Credit Agreement, dated as of May 20, 2024, by and among Astrana Health, Inc., as borrower, Astrana Health Management, Inc., as guarantor, the lenders party thereto, and Truist Bank, as administrative agent, issuing bank and the swingline lender. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASTRANA HEALTH, INC. Date: May 21, 2024 By: /s/ Brandon Sim Name: Brandon Sim Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing